BNP Risk Score: Predicting Heart Failure With a Simple Blood Test

Development of a risk score for BNP ≥100 pg/mL enables prediction of elevated natriuretic peptide levels using clinical variables before blood testing.

Arafa, Ahmed et al.·BMC cardiovascular disorders·2025·Moderate Evidencecohort
RPEP-09962CohortModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
cohort
Evidence
Moderate Evidence
Sample
N=2809
Participants
Japanese adults aged ≥40 years from the Suita Study population-based cohort

What This Study Found

Development of a risk score for BNP ≥100 pg/mL enables prediction of elevated natriuretic peptide levels using clinical variables before blood testing.

Key Numbers

2,809 participants aged ≥40 years. BNP threshold: ≥100 pg/mL. BNP measured every 2 years.

How They Did This

In publication.

Why This Research Matters

Relevant to peptide therapeutics.

The Bigger Picture

Advances peptide evidence.

What This Study Doesn't Tell Us

In publication.

Questions This Raises

  • ?Long-term implications?
  • ?Evidence comparison?
  • ?Next steps?

Trust & Context

Key Stat:
Key finding Development of a risk score for BNP ≥100 pg/mL enables prediction of elevated natriuretic peptide le
Evidence Grade:
Based on design.
Study Age:
Published in 2025.
Original Title:
Developing a risk score for B-type natriuretic peptide (BNP) ≥ 100 pg/ml levels: the suita study.
Published In:
BMC cardiovascular disorders, 25(1), 649 (2025)
Database ID:
RPEP-09962

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What does this mean?

Development of a risk score for BNP ≥100 pg/mL enables prediction of elevated natriuretic peptide levels using clinical variables before blood testing.

How reliable?

Consult publication.

Read More on RethinkPeptides

Cite This Study

RPEP-09962·https://rethinkpeptides.com/research/RPEP-09962

APA

Arafa, Ahmed; Kato, Yuka; Matsumoto, Chisa; Khairan, Paramita; Maeda, Saori; Kokubo, Yoshihiro. (2025). Developing a risk score for B-type natriuretic peptide (BNP) ≥ 100 pg/ml levels: the suita study.. BMC cardiovascular disorders, 25(1), 649. https://doi.org/10.1186/s12872-025-05031-w

MLA

Arafa, Ahmed, et al. "Developing a risk score for B-type natriuretic peptide (BNP) ≥ 100 pg/ml levels: the suita study.." BMC cardiovascular disorders, 2025. https://doi.org/10.1186/s12872-025-05031-w

RethinkPeptides

RethinkPeptides Research Database. "Developing a risk score for B-type natriuretic peptide (BNP)..." RPEP-09962. Retrieved from https://rethinkpeptides.com/research/arafa-2025-developing-a-risk-score

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.